Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-112056
Filing Date
2025-08-28
Accepted
2025-08-28 17:10:04
Documents
1
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4405
  Complete submission text file 0000950170-25-112056.txt   5946
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 777 W 41ST SUITE 401 MIAMI BEACH FL 33140
Business Address
To Lucy (Reporting) CIK: 0002032049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251274616